Epitalon — Dosing & Research | Peptide Chats
Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

Epitalon

Also known as: Epithalon, Epithalone, Epithalон, AEDG peptide, Ala-Glu-Asp-Gly, Epitalon tetrapeptide

Synthetic tetrapeptide / pineal gland peptide bioregulator

Research chemicalLast updated: October 31, 2026Based on 44 peer-reviewed studies

What it is

Epitalon is a peptide used in the longevity community for anti-aging effects, including telomere support and circadian rhythm normalization. It is believed to work by stimulating the pineal gland and promoting melatonin production. Not FDA-approved; primarily studied in Russian clinical research with limited independent replication.

The scientific side

Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide derived from the amino acid composition of Epithalamin, a bovine pineal gland extract, and subsequently identified within the pineal gland polypeptide complex itself (PMID 29124531; PMID 40141333). Its proposed mechanisms of action include: (1) Telomerase activation and telomere elongation — Epitalon induces expression of the telomerase catalytic subunit (hTERT), increases telomerase enzyme activity, and extends telomere length in normal human somatic cells and cancer cell lines; in cancer cells, Alternative Lengthening of Telomeres (ALT) activation also contributes (PMID 40908429; PMID 12937682; PMID 15455129). (2) Epigenetic/chromatin remodeling — Epitalon binds preferentially to histone H1/3 and H1/6 and interacts specifically with DNA at CNG and CAG nucleotide sequences, potentially regulating gene transcription via an epigenetic mechanism; it induces deheterochromatinization (decondensation) of heterochromatin in lymphocytes from aged individuals (PMID 32019204; PMID 22117547; PMID 14647006; PMID 24323970; PMID 27259496; PMID 37042594). (3) Melatonin synthesis regulation — Epitalon stimulates arylalkylamine-N-acetyltransferase (AANAT) and pCREB synthesis in pinealocyte culture, increasing melatonin levels; in elderly humans and old monkeys, it restores nocturnal melatonin secretion and circadian rhythm amplitude (PMID 22816096; PMID 17969590; PMID 23289226). (4) Antioxidant effects — Epitalon possesses antioxidant properties, modulates reactive oxygen species (ROS), stimulates antioxidant enzymes (SOD, glutathione peroxidase), and reduces lipid peroxidation products; these effects may exceed those of melatonin in some contexts (PMID 17317455; PMID 18546826). (5) Immune modulation — Epitalon modulates interleukin-2 mRNA levels, influences mitogenic activity of thymocytes, and affects lymphocyte proliferation and cytokine expression (PMID 40141333; PMID 35408963). (6) Anti-senescence — Epitalon targets the SUV39H1 axis to partially eliminate therapy-induced senescent cells in NKTCL models. (7) Neurogenic differentiation — Epitalon increases expression of neurogenic differentiation markers (Nestin, GAP43, β-Tubulin III, Doublecortin) in human gingival mesenchymal stem cells. (8) Neuroendocrine effects — Intranasal administration increases cortical neuron discharge frequency in rats. The precise primary receptor or molecular target remains uncertain.

Class: Synthetic tetrapeptide / pineal gland peptide bioregulator

Administration & storage

Administration
Subcutaneous injection (PMID: 19110597)Intranasal administration (PMID: 17955380; PMID: 18264770)In vitro culture medium addition (PMID: 35413689; PMID: 40908429; PMID: 39788414)Injection — route not further specified (PMID: 19432169; PMID: 17317455)
Storage
No storage conditions for Epitalon are described in the reviewed abstracts.
Cautions
Long-term safety data and systematic validation are lacking for Epitalon in humans; a 2026 review stated it 'lacks long-term safety data and systematic validation'.,One review noted that 'more mechanistic investigations are needed to confirm Epitalon's benefits and safety' before broader therapeutic use, particularly for ophthalmic indications.,Epitalon has been identified in illegal pharmaceutical preparations, indicating risk of unregulated sourcing and uncertain purity or identity.,Compounded peptide products raise safety concerns regarding formulation, sterility, and dosing consistency; these concerns apply to all compounded peptides.,Sterile technique is essential for any injectable preparation to prevent contamination (universal caution).

Legal & regulatory status

US FDA

Not stated in reviewed literature — requires manual verification. One review noted that 'non-approved peptides showed promising preclinical and limited clinical evidence but lack long-term safety data and systematic…

WADA

Not stated in reviewed literature — requires manual verification. One review referenced WADA regulatory databases in its methods but did not report a specific WADA status for Epitalon.

Health Canada

Not stated in reviewed literature — requires manual verification.